GammaDelta Therapeutics

38 Jermyn Street
London
SW1Y 6DN
United Kingdom

Show jobs for this employer

About GammaDelta Therapeutics

GammaDelta Therapeutics is developing the potential of gamma delta (?d) cells to create improved immunotherapy of cancer and other serious diseases. The company plans to exploit unique properties of tissue resident ?d T cells for effective immunotherapy.
YEAR FOUNDED:
July 2016
LEADERSHIP:
Founder and Interim CEO: Raj Mehta

8 articles with GammaDelta Therapeutics